Labomar Overview
- Year Founded
-
1998
- Status
-
Private
- Employees
-
365
- Latest Deal Type
-
Debt - Acquisition
- Financing Rounds
-
9
- Investments
-
10
Labomar General Information
Description
Manufacturer of nutraceuticals, medical devices, cosmetics and foods for special medical purposes. The company provides bespoke product development and industrial-scale production through its in-house services, thereby ensuring high-quality and safe formulations for global healthcare
Contact Information
Website
www.labomar.comCorporate Office
- Via North Sauro, 35/l
- 31036 Istrana(Treviso)
- Italy
Corporate Office
- Via North Sauro, 35/l
- 31036 Istrana(Treviso)
- Italy
Labomar Timeline
Labomar Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Labomar Patents
Labomar Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026180963-A1 | A composition comprising myrtus communis extract and olea europea extract for the maintenance and/or in the restoration of physiological blood lipid levels | Pending | 25-Feb-2025 | ||
| WO-2026078513-A1 | Formulation comprising a mucoadhesive, washout-resistant and film- forming association | Pending | 07-Oct-2024 | ||
| WO-2026074521-A1 | Emulsions for use in oral and cosmetic formulations | Pending | 04-Oct-2024 | ||
| EP-4827409-A1 | Compositions for improving the dispersion of probiotics in oily suspensions | Pending | 18-Dec-2023 | ||
| WO-2025133941-A1 | Compositions for improving the dispersion of probiotics in oily suspensions | Inactive | 18-Dec-2023 | A23L33/135 |
Labomar Signals
Labomar Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Labomar Investments & Acquisitions (10)
Labomar’s most recent deal was a Buyout/LBO with Pharmia. The deal was made on 25-Sep-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Pharmia | 25-Sep-2025 | Buyout/LBO | Medical Supplies | ||
| Laboratorios Entema | 06-Aug-2024 | Merger/Acquisition | Personal Products | ||
| Sphera Encapsulation | 01-Jul-2024 | Merger/Acquisition | Other Commercial Services | ||
| Sphera Encapsulation | 01-Sep-2023 | Corporate | Other Commercial Services | ||
| Welcare Industries | 27-Dec-2021 | Secondary Transaction - Private | Medical Supplies |
Labomar Affiliates
Subsidiaries (7)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Sphera Encapsulation | Verona, Italy | 2016 | |
| Welcare Research S.R.L. Societa Benefit | Milan, Italy | 2015 | |
| Labiotre | Florence, Italy | 2011 | |
| Welcare Industries | Milan, Italy | 2001 | |
| Laboratorios Entema | Palau-solita i Plegamans, Spain | 1995 |
Labomar FAQs
-
When was Labomar founded?
Labomar was founded in 1998.
-
Where is Labomar headquartered?
Labomar is headquartered in Istrana, Italy.
-
What is the size of Labomar?
Labomar has 365 total employees.
-
What industry is Labomar in?
Labomar’s primary industry is Pharmaceuticals.
-
Is Labomar a private or public company?
Labomar is a Private company.
-
What is Labomar’s current revenue?
The current revenue for Labomar is .
-
How much funding has Labomar raised over time?
Labomar has raised $186M.
-
Who are Labomar’s investors?
CCP No. 7.2, Charterhouse Capital Partners, and LBM Holding have invested in Labomar.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process